PRKDC and neoplasm: In cases of protein overexpression, the inhibition of DNA-PKcs is promising as it would not only reduce the DNA repair abilities of the tumor but may also downregulate transcriptional programs and metabolic pathways that contribute to tumor progression and metastasis.